These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3611449)

  • 1. Generalized pustular psoriasis associated with withdrawal of topical clobetasol-17-propionate.
    Telfer NR; Dawber RP
    J Am Acad Dermatol; 1987 Jul; 17(1):144-5. PubMed ID: 3611449
    [No Abstract]   [Full Text] [Related]  

  • 2. Intermittent topical treatment of psoriasis with clobetasol propionate ("Dermovate").
    Svartholm H; Larsson L; Frederiksen B
    Curr Med Res Opin; 1982; 8(3):154-7. PubMed ID: 6751703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clobetasol propionate ointment 0.05% versus diflorasone diacetate ointment 0.05% in moderate to severe psoriasis.
    Jegasothy BV
    Int J Dermatol; 1990 Dec; 29(10):729-30. PubMed ID: 2269571
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenal suppression following low-dose topical clobetasol propionate.
    Ohman EM; Rogers S; Meenan FO; McKenna TJ
    J R Soc Med; 1987 Jul; 80(7):422-4. PubMed ID: 3656312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
    van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
    Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
    [No Abstract]   [Full Text] [Related]  

  • 6. Clobetasol propionate ointment once daily versus fluocinonide ointment three times daily in psoriasis.
    Bickers D; Cornell R; Kamm AR; Bauman WE; Handler RM; Medansky RS; Sturm HM
    Int J Dermatol; 1988; 27(1):54-5. PubMed ID: 3278991
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
    Jacobson C; Cornell RC; Savin RC
    Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
    Beck M; Berger C; Filipp N; Hundertmark U; Loewel R
    Z Hautkr; 1981 Aug; 56(16):1066-70. PubMed ID: 7027655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrophic skin striae following the use of clobetasol propionate ointment.
    Hardie RA; Waring AJ; Barnetson RS
    Practitioner; 1977 Sep; 219(1311):376-8. PubMed ID: 928283
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with 0.05% clobetasol propionate creams.
    Richards RN
    J Am Acad Dermatol; 1985 May; 12(5 Pt 1):891-3. PubMed ID: 4008693
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination of cyclosporine A and topical corticosteroid in the treatment of psoriasis.
    Griffiths CE; Powles AV; Baker BS; Fry L; Valdimarsson H
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):50-2. PubMed ID: 3381302
    [No Abstract]   [Full Text] [Related]  

  • 12. Intermittent treatment of psoriasis with clobetasol propionate.
    Hradil E; Lindström C; Möller H
    Acta Derm Venereol; 1978; 58(4):375-7. PubMed ID: 82342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical clobetasol-17-propionate: review of its clinical efficacy and safety.
    Olsen EA; Cornell RC
    J Am Acad Dermatol; 1986 Aug; 15(2 Pt 1):246-55. PubMed ID: 3528243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis treatment: faster clearance when UVB-dithranol is combined with topical clobetasol propionate.
    Lidbrink P; Johannesson A; Hammar H
    Dermatologica; 1986; 172(3):164-8. PubMed ID: 3699218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of quarter strength clobetasol propionate in Unguentum Merck with betamethasone valerate in psoriasis.
    Stankler L
    Br J Clin Pract; 1983; 37(11-12):389-91. PubMed ID: 6367795
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical corticosteroids.
    Möller H
    Int J Dermatol; 1989 May; 28(4):279. PubMed ID: 2722349
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superpotent topical steroid treatment of psoriasis vulgaris--clinical efficacy and adrenal function.
    Katz HI; Hien NT; Prawer SE; Mastbaum LI; Mooney JJ; Samson CR
    J Am Acad Dermatol; 1987 Apr; 16(4):804-11. PubMed ID: 3553247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clobetasol propionate versus fluocinonide creams in psoriasis and eczema.
    Jegasothy B; Jacobson C; Levine N; Millikan L; Olsen E; Pinnell S; Cole G; Weinstein G; Porter M
    Int J Dermatol; 1985 Sep; 24(7):461-5. PubMed ID: 3902682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betamethasone dipropionate cream for the treatment of psoriasis. A double-blind comparison with clobetasol propionate cream.
    Verdich J; Karlsmark T
    Dermatologica; 1985; 170(3):152-5. PubMed ID: 3979642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.